SynthesisPediatric pulmonology2026
The Role of Vitamin D in Severity and Control of Asthma in Children and Adolescents: A Systematic Review and Meta-Analysis.
Synthesis in Pediatric pulmonology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextVitamin D may modulate the inflammatory processes involved in asthma.
objectiveTo synthesize evidence on the association between serum 25-hydroxyvitamin D levels and asthma control, severity, pulmonary function, and inflammatory markers in children and adolescents. DATA SOURCES: MEDLINE PubMed, BIREME, EBSCOhost, Scopus, Web of Science, EMBASE, Cochrane Library, and ProQuest until May 2025. STUDY SELECTION: Eligible studies enrolled participants aged 2-18 years with clinically diagnosed asthma and evaluated serum vitamin D levels in relation to asthma severity and/or control and pulmonary function parameters or type 2 inflammatory biomarkers. We included observational and randomized studies. DATA EXTRACTION: The risk of bias for studies was assessed. Random-effects models estimated pooled outcomes. The heterogeneity was assessed using Cochran's Q and the I² statistic.
resultsForty-one studies (7780 participants) were included; 25 contributed to meta-analyses. Children with asthma had significantly lower serum 25(OH)D levels than healthy controls (mean difference -4.89 ng/mL; 95% CI -7.38 to -2.40; p < 0.001). Severe asthma was associated with lower vitamin D compared with mild disease (-4.21 ng/mL; 95% CI -6.43 to -1.98; p = 0.0002). No significant difference was observed between controlled and uncontrolled asthma. Correlations with pulmonary function were weak and non-significant (FEV₁ r = 0.18; p = 0.08). Vitamin D showed a moderate inverse association with total IgE (r = -0.37; p = 0.02), but not with eosinophil counts or IL-10. Heterogeneity was high across analyses.
conclusionsChildren with asthma exhibit lower serum vitamin D levels compared with healthy peers, and these levels are inversely associated with asthma severity and total IgE. No consistent associations were observed with pulmonary function or asthma control. Further research is needed to determine whether correcting vitamin D deficiency can improve clinical and immunologic outcomes in pediatric asthma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.